Alcon (ALC) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $0.91
- Estimate
- $0.89
- Surprise
- +2.3%
- Score today
- 5.4/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
Alcon (ALC) beat the $0.89 estimate with adjusted EPS of $0.91 — a modest 2.3% upside surprise.
Coverage in the report window
- Needham Reiterates Buy on Alcon, Maintains $98 Price Target — benzinga, 2026-11-11
- Stock Market Today: Dow Jones, S&P 500 Futures Rise as Bessent Urges US-China to 'De-Risk' — CRWV, RGTI, FNV in Focus — benzinga, 2026-11-11
- CORRECTION: Alcon Q3 Adj. EPS $0.91 Beats $0.87 Estimate, Sales $2.717B Miss $2.737B Estimate — benzinga, 2026-11-10
Where TrendMatrix's rating stands now
TrendMatrix currently rates ALC Hold at 5.4/10; no pre/post engine snapshot brackets this report.
3 of the last 4 quarters beat the estimate; this quarter's +2.3% surprise compares with a +4.1% four-quarter average.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Strong earnings beat streak (3/4)
What argues against it
- Analyst target reached - limited upside remaining
- Target reached (-0.4% upside)
- Negative risk/reward — downside exceeds upside
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $74.06
- Stop
- $69.98
The stock trades at 56.1× trailing but 18.8× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: trading volume is running 2.5× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-11-11 — shown for context, not personalized investment advice.
ALC at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Instruments & Supplies
- Market cap
- $35.80B
- P/E (fwd)
- 18.8
- P/E (ttm)
- 56.1
- 52-week range
- $61.84–$87.64
- Off 52-week high
- 15.5%
- RSI (14)
- 68
- Volume vs avg
- 2.54×
- Score today
- 5.4/10